Stocks
Supernus Pharmaceuticals, Inc.SUPN
NASDAQHealthcarePharmaceuticals$49.91-1.09%
Focused on treatments for central nervous system disorders, the company develops and commercializes prescription drugs for conditions such as epilepsy, ADHD, and Parkinson’s disease. Its portfolio includes several marketed products alongside a pipeline of neurological therapies under development. In...
Market Cap: $2.9B52W Range: $29.16 – $59.68
Congressional Interest in Supernus Pharmaceuticals, Inc. (SUPN)
3 members of Congress have disclosed 12 trades in Supernus Pharmaceuticals, Inc. (SUPN), a Healthcare company. The buy/sell breakdown shows 9 purchases versus 3 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
12
Unique Politicians
3
Buys
9
Sells
3
Who in Congress Is Trading SUPN?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-03-03 | Gilbert Cisneros | buy | $1K – $15K |
| 2025-12-11 | Gilbert Cisneros | buy | $1K – $15K |